IMMUNIC, INC. — Director's Dealing 2020

Jul 22, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2020-07-20

Reporting Person: Vitt Daniel (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-20	Common Stock	S	5000	$14.4401	Disposed	364177	Indirect
2020-07-21	Common Stock	S	1300	$15.6229	Disposed	362877	Indirect

Footnotes

F1: These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Plan"). The Plan was adopted in connection with certain tax liabilities related to the issuance of shares in the April 2019 exchange transaction between the Issuer (then known as Vital Therapies, Inc.) and Immunic AG.

F2: The Reporting Person is Managing Director of Listrax UG (haftungsbeschrankt), which is the record holder of 362,877 shares of common stock of the Issuer, and exercises voting and dispositive power over such shares.